Marcial, Shaira Mae H.
HRN: 24-30-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2023
METRONIDAZOLE 500MG (TAB)
12/26/2023
01/02/2024
PO
500mg
TID X 7 Days
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes